Literature DB >> 33029723

Sleep Issues in Parkinson's Disease and Their Management.

José Rafael P Zuzuárregui1, Emmanuel H During2.   

Abstract

Parkinson's disease (PD) is an alpha-synucleinopathy that leads to prominent motor symptoms including tremor, bradykinesia, and postural instability. Nonmotor symptoms including autonomic, neurocognitive, psychiatric symptoms, and sleep disturbances are also seen frequently in PD. The impact of PD on sleep is related to motor and nonmotor symptoms, in addition to the disruption of the pathways regulating sleep by central nervous system pathology. Rapid eye movement sleep behavior disorder is a parasomnia that can lead to self-injury and/or injury to partners at night. Restless legs syndrome is a subjective sensation of discomfort and urge to move the legs prior to falling asleep and can lead to insomnia and reduced sleep quality. Excessive daytime sleepiness is common in PD and exerts a negative impact on quality of life in addition to increasing the risk of falls. Obstructive sleep apnea is a breathing disorder during sleep that can cause frequent awakenings and excessive daytime sleepiness. Circadian rhythm dysfunction can lead to an advanced or delayed onset of sleep in patients and create disruption of normal sleep and wake times. All of these disorders are common in PD and can significantly reduce sleep quantity, sleep quality, or quality of life for patients and caretakers. Treatment approaches for each of these disorders are distinct and should be individualized to the patient. We review the literature regarding these common sleep issues encountered in PD and their treatment options.

Entities:  

Keywords:  Parkinson’s disease; SLEEP; circadian rhythm disorder; excessive daytime sleepiness (EDS); insomnia; obstructive sleep apnea (OSA); rapid eye movement sleep behavior disorder (RBD); restless legs syndrome (RLS)

Year:  2020        PMID: 33029723      PMCID: PMC7851262          DOI: 10.1007/s13311-020-00938-y

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  163 in total

1.  Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.

Authors:  Raffaella Di Giacopo; Alfonso Fasano; Davide Quaranta; Giacomo Della Marca; Francesco Bove; Anna Rita Bentivoglio
Journal:  Mov Disord       Date:  2012-01-30       Impact factor: 10.338

2.  The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies.

Authors:  Andrea Galbiati; Laura Verga; Enrico Giora; Marco Zucconi; Luigi Ferini-Strambi
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

3.  Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.

Authors:  Tayyabah Yousaf; Gennaro Pagano; Flavia Niccolini; Marios Politis
Journal:  J Neurol Sci       Date:  2018-02-21       Impact factor: 3.181

4.  Bright light therapy with a head-mounted device for anxiety, depression, sleepiness and fatigue in patients with Parkinson's disease.

Authors:  Jean-Marc Raymackers; Mariana Andrade; Eugenie Baey; Margaux Vanneste; Frédéric Evrard
Journal:  Acta Neurol Belg       Date:  2019-09-30       Impact factor: 2.396

5.  Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment.

Authors:  Diego Garcia-Borreguero; Irene Cano-Pumarega; Celia Garcia Malo; Jose Antonio Cruz Velarde; Juan José Granizo; Vivian Wanner
Journal:  Sleep Med       Date:  2018-12-26       Impact factor: 3.492

6.  An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Yuichi Esaki; Tsuyoshi Kitajima; Shigefumi Koike; Hiroshige Fujishiro; Yasuyo Iwata; Akiko Tsuchiya; Marina Hirose; Nakao Iwata
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

7.  An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder.

Authors:  Raffaele Ferri; Sara Marelli; Luigi Ferini-Strambi; Alessandro Oldani; Francesca Colli; Carlos H Schenck; Marco Zucconi
Journal:  Sleep Med       Date:  2012-10-23       Impact factor: 3.492

8.  Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.

Authors:  Bradley F Boeve; Michael H Silber; Tanis J Ferman
Journal:  Sleep Med       Date:  2003-07       Impact factor: 3.492

9.  SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE.

Authors:  Priti Gros; Aleksandar Videnovic
Journal:  Curr Sleep Med Rep       Date:  2017-07-06

10.  Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.

Authors:  Kenji Uchino; Makoto Shiraishi; Keita Tanaka; Masashi Akamatsu; Yasuhiro Hasegawa
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

View more
  5 in total

1.  Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic review.

Authors:  Takashi Tsuboi; Yuki Satake; Keita Hiraga; Katsunori Yokoi; Makoto Hattori; Masashi Suzuki; Kazuhiro Hara; Adolfo Ramirez-Zamora; Michael S Okun; Masahisa Katsuno
Journal:  NPJ Parkinsons Dis       Date:  2022-06-13

Review 2.  Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.

Authors:  Reyisha Taximaimaiti; Xingguang Luo; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 3.  Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical Scenarios.

Authors:  Stuart H Isaacson; Sagari Betté; Rajesh Pahwa
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-07-23

4.  Effects of remote ischemic conditioning on sleep complaints in Parkinson's disease-rationale, design, and protocol for a randomized controlled study.

Authors:  Qiling Ji; Xuemei Wang; Wenbo Zhao; Melissa Wills; Ho Jun Yun; Yanna Tong; Lipeng Cai; Xiaokun Geng; Yuchuan Ding
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

5.  Constructing prediction models for excessive daytime sleepiness by nomogram and machine learning: A large Chinese multicenter cohort study.

Authors:  Penghui Deng; Kun Xu; Xiaoxia Zhou; Yaqin Xiang; Qian Xu; Qiying Sun; Yan Li; Haiqing Yu; Xinyin Wu; Xinxiang Yan; Jifeng Guo; Beisha Tang; Zhenhua Liu
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.